- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Malignant Lymph Node Neoplasm in South Africa
Total 1624 results
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingMalignant MelanomaUnited States, Australia, Austria, Brazil, Canada, Chile, China, France, Germany, Israel, Italy, Korea, Republic of, Poland, South Africa, Spain, Sweden, Switzerland, United Kingdom
-
Medical University of South CarolinaTerminatedMyelodysplastic Syndromes | LeukemiaUnited States
-
BeiGeneCompletedB-cell Lymphoid MalignanciesAustralia, Korea, Republic of, United States
-
CelgeneCompletedMelanoma | Lymphoma | Multiple Myeloma | Pancreatic Cancer | Non-Small Cell Lung CancerAustralia
-
SanofiCompletedHematopoietic NeoplasmAustria, Germany, Italy, Spain, United Kingdom, France, Belgium, Israel, Sweden, Australia, United States, Lithuania, Portugal, Korea, Republic of, Singapore, Taiwan, Mexico, Brazil, Canada, Hungary, Ireland, Poland, Romania, Russian... and more
-
QBiotics Group LimitedRecruitingHead and Neck CancerUnited Kingdom, Australia
-
National Cancer Institute (NCI)CompletedRecurrent Salivary Gland Carcinoma | Salivary Gland Adenoid Cystic Carcinoma | Stage IV Major Salivary Gland Cancer AJCC v7 | Malignant Salivary Gland NeoplasmUnited States, Canada
-
Portsmouth Hospitals NHS TrustBritish Lung Foundation; University of OxfordCompletedMesothelioma, MalignantUnited Kingdom, Australia
-
Bristol-Myers SquibbNo longer availableMalignant MelanomaUnited States, Canada
-
CelgeneUniversity of ArizonaCompletedMalignant MelanomaCanada, United States, Australia, United Kingdom, France, Italy, Spain, Germany, Netherlands
-
UNC Lineberger Comprehensive Cancer CenterAstraZenecaActive, not recruitingOral Cancer | Larynx | Lip | Digestive Organs--DiseasesUnited States
-
Gary MorrowNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompletedMultiple Myeloma | InfectionUnited States, Peru, South Africa
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Eli Lilly and CompanyCompletedHead and Neck NeoplasmsUnited States
-
AccentureCompletedHematologic MalignanciesKorea, Republic of, Australia, Canada
-
Nuvation Bio Inc.TerminatedGlioma | Breast Cancer | Glioblastoma | Advanced Breast Cancer | Prostate Cancer | Metastatic Breast Cancer | Recurrent Glioblastoma | Breast Carcinoma | Castration-resistant Prostate Cancer | Prostate Neoplasm | Cancer of the Prostate | Prostatic Cancer | Glioma, Malignant | Cancer of Breast | Malignant Tumor of Breast and other conditionsUnited States
-
AstraZenecaTerminatedLymphoma | Non-Hodgkin Lymphoma | NHLUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedPain | Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Lymphoproliferative Disorder | Myelodysplastic/Myeloproliferative...United States
-
GlaxoSmithKlineCompletedThrombocytopaeniaUnited States
-
Novartis PharmaceuticalsTerminatedPhilidelphia Positive Chronic Myeloid LeukaemiaAustralia
-
Kartos Therapeutics, Inc.GlaxoSmithKlineCompletedMelanoma | Cancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States, Australia
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
Bristol-Myers SquibbCompletedAdvanced TumorsUnited States, France, Australia, Spain, Canada
-
Archigen Biotech LimitedCompletedLymphoma, FollicularUnited States, Korea, Republic of, Hungary, Spain, Turkey, Czechia, Italy, France, United Kingdom, Germany, South Africa, Australia, Chile, Mexico
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Spain, Hungary, Israel, United Kingdom, Australia, Austria, Belgium, Czechia, France, Germany, Italy, Netherlands, Russian Federation, Sweden, Switzerland, Canada, New Zealand, Norway
-
National Cancer Institute (NCI)CompletedLymphomaUnited States, Australia, South Africa, Peru, Puerto Rico
-
Sydney Children's Hospitals NetworkGerman Cancer Research Center; Australian & New Zealand Children's Haematology... and other collaboratorsActive, not recruitingChildhood Cancer | Relapsed Cancer | Refractory Cancer | Childhood Leukemia | Childhood Solid Tumor | Childhood Brain TumorAustralia
-
Western Sydney Local Health DistrictRecruitingFamilial Adenomatous PolyposisAustralia
-
City of Hope Medical CenterNational Cancer Institute (NCI)Completed
-
Ultimovacs ASACompletedMalignant MelanomaUnited States, Belgium, United Kingdom, Norway
-
Trans Tasman Radiation Oncology GroupAustralasian Leukaemia and Lymphoma GroupCompletedFollicular LymphomaAustralia, New Zealand, Canada
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Puerto Rico, South Africa
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedN-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous MelanomaUnited States, Sweden, Australia, France, Italy, South Africa, Spain, United Kingdom, Germany, Netherlands, Israel, New Zealand, Belgium, Switzerland
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMantle Cell Lymphoma RefractoryAustralia
-
OncotherapeuticsUnknownMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Medical University of South CarolinaCelgene CorporationCompletedLarge B-Cell Diffuse LymphomaUnited States
-
BeiGeneRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Non-small Cell Lung Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer | Hormone-receptor-positive...Australia, United States
-
BeiGeneCompletedLymphoma | LeukemiaChina, Australia
-
CStone PharmaceuticalsRecruitingAdvanced Solid Tumor | Advanced LymphomaChina, Australia, United States
-
Peter MacCallum Cancer Centre, AustraliaActive, not recruitingHodgkin LymphomaAustralia, New Zealand
-
ExelixisActive, not recruitingA Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (STELLAR-001)Renal Cell Carcinoma | Colorectal Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor Positive Breast Carcinoma | Neoplasm MalignantUnited States, Australia, Belgium, Czechia, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
SanofiCompletedHead and Neck NeoplasmsUnited States
-
SanofiCompletedHematopoietic NeoplasmUnited States, Austria, Belgium, Canada, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
Innate PharmaRecruitingNon Hodgkin LymphomaUnited States, Australia
-
SanofiActive, not recruitingMalignant Melanoma | Squamous Cell Carcinoma of SkinGermany, Spain, France, Chile, United States, Australia, Italy
-
BayerImmunoGen and MorphoSysCompletedMesotheliomaBelgium, France, United States, Canada, Spain, Turkey, United Kingdom, Australia, Finland, Italy, Poland, Korea, Republic of, Netherlands, Russian Federation
-
Rhizen Pharmaceuticals SACompletedNon Hodgkin LymphomaUnited States, Australia
-
Adlai Nortye Biopharma Co., Ltd.RecruitingAdvanced Solid Tumor | Advanced LymphomaUnited States, China
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedHead and Neck CancerUnited States, Canada